Medical Press Release - Page 3 of 12 - Medika Life : Keeping you informed

A new survey finds 52 percent of individuals feel their symptoms are “ignored, dismissed, or not believed” when seeking medical treatment. That number rises to 6-in-10 within the Hispanic community.

New Data Shows No Evidence of COVID-19 Spread in Gyms

Medika Life - October 2, 2020

Of More than 49.4 Million Health Club Visits, Only 0.0023 Percent Tested Positive for COVID-19

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life - August 6, 2020

FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

The 50 Most Influential Leaders in Pharmacy Awards Opens for Nominations

Medika Life - October 4, 2021

Nominations for the 50 most influential individuals in Pharma are now open. Join the Pharmacy Podcast Network in celebrating your choices

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

FINN Partners Brings Aboard the Pharmacy Podcast Network

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

MITRE-Harris Poll Survey Finds Half of Patients in the US Feel Ignored or Doubted When Seeking Medical Treatment

New Data Shows No Evidence of COVID-19 Spread in Gyms

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

The 50 Most Influential Leaders in Pharmacy Awards Opens for Nominations

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories